Michael Rugaard Jensen Selected Research

Aftercare (After-Treatment)

4/2003

Reduced hepatic tumor incidence in cyclin G1-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Rugaard Jensen Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 04/2003
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2013
1	Melanoma (Melanoma, Malignant) 04/2010
1	Pathologic Constriction (Stenosis) 03/2010
1	Thrombosis (Thrombus) 03/2010
1	Atherosclerotic Plaque (Atheroma) 03/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2010
1	Carcinogenesis 01/2008

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2006
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2013 - 01/2008
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 06/2013 - 01/2008
2	Molecular Chaperones (Chaperone, Molecular)IBA 11/2012 - 08/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2023
1	AlpelisibIBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	siremadlinIBA 01/2017
1	Tumor Suppressor Protein p53IBA 01/2017
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2017
1	Proto-Oncogene Proteins c-mdm2IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 06/2013
1	ErbB Receptors (EGF Receptor)IBA 06/2013
1	NVP-BEP800IBA 04/2010
1	Oxygen (Dioxygen)IBA 03/2010
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	Cyclin G1IBA 04/2003
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 04/2003
1	CyclinsIBA 04/2003

Therapy/Procedure

4	Therapeutics 01/2019 - 03/2010
1	Oral Administration 04/2010
1	Stents 03/2010
1	Drug-Eluting Stents 03/2010
1	Aftercare (After-Treatment) 04/2003